We found different expression levels of BTLA, BTN2AA2, CD160, CD226, CD27, CD276, CD40LG, CD96, CTLA4, TIGIT between the two risk groups of patients with NSCLC. This evidence concerns the gene CD160 and non-small cell lung carcinoma.